Zuga Matt
CFO & Chief Business Officer
Zuga Matt has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jan 23, 2026.
On the most recent filing, Zuga Matt is listed as CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc. Inside the rolling window, Zuga Matt reported no open-market purchases and 6 open-market sales totaling $50K in ABOS. The largest disclosed transaction in the window is a sale of 6,888 ABOS shares on Jan 8, 2026, worth $13K.
Companies traded
Other insiders at ABOS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$50K
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ABOS | CFO & Chief Business Officer | Sale | 2,473 | $4K | Jan 23 | SEC ↗ | |
| ABOS | CFO & Chief Business Officer | Sale | 1,687 | $3K | Jan 23 | SEC ↗ | |
| ABOS | CFO & Chief Business Officer | Sale | 6,888 | $13K | Jan 12 | SEC ↗ | |
| ABOS | CFO & Chief Business Officer | Sale | 4,000 | $8K | Jan 7 | SEC ↗ | |
| ABOS | CFO & Chief Business Officer | Sale | 5,100 | $10K | Jan 7 | SEC ↗ | |
| ABOS | CFO & Chief Business Officer | Sale | 5,805 | $12K | Jan 7 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Zuga Matt made?
Zuga Matt has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Zuga Matt trade?
Zuga Matt has filed SEC Form 4 disclosures for 1 company, including ABOS.
When was Zuga Matt's most recent SEC Form 4 filing?
Zuga Matt's most recent SEC Form 4 filing on Tracefour is dated Jan 23, 2026.
What is Zuga Matt's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Zuga Matt is listed as CFO & Chief Business Officer.
What is Zuga Matt's total buy and sell value in the current window?
Inside the rolling retention window, Zuga Matt bought $0 and sold $50K based on SEC Form 4 filings.
What was Zuga Matt's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,888 ABOS shares on 2026-01-08, worth $13K, per SEC Form 4 filings.